Okinawa Pharmaceuticals Private Limited

Produces and sells a variety of pharmaceutical products including corcell, vafine, and esocall-D.

2015 | Mumbai, Maharashtra (India) | Active
Last Updated:

Okinawa Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 4 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 3.40 M
  • Revenue Growth 42.64%
  • Profit Growth -6.78%
  • Ebitda 27.90%
  • Net Worth 142.61%
  • Total Assets 40.49%

About Okinawa Pharmaceuticals

Okinawa Pharmaceuticals Private Limited (OPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 December 2015 (Nine years and four months 17 days old ). Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹3.40 M.

Ramadevi Ananthu, Chandra Eduru, Srujana Bitra, and Three other members serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U51101MH2015PTC306595

  • Company No.

    306595

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    30 Dec 2015

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Okinawa Pharmaceuticals Private Limited offer?

Okinawa Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Vitamin Tablets & Capsules, Sexual Wellness Products, Fertility Enhancer, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Respiratory System Drugs.

Company report

Okinawa Pharmaceuticals Private Limited

Explore comprehensive data for Okinawa Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Okinawa Pharmaceuticals?

Board Members (6)

NameDesignationAppointment DateStatus
Ramadevi Ananthu Country flag representing In Director 30-Dec-2015Current
Chandra Eduru Country flag representing In Director 26-Dec-2017Current
Srujana Bitra Country flag representing In Additional Director 06-Apr-2024Current
Venkatrao Mandati Country flag representing In Additional Director 04-Apr-2024Current
Anjaneyulu Boddapati Country flag representing In Additional Director 06-Apr-2024Current
Divyakolu Ramanjaneyulu Country flag representing In Additional Director 04-Apr-2024Current

Financial Performance of Okinawa Pharmaceuticals.

Okinawa Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 42.64% increase. The company also saw a slight decrease in profitability, with a 6.78% decrease in profit. The company's net worth Soared by an impressive increase of 142.61%.

Okinawa Pharmaceuticals revenue growth over time
Okinawa Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
42.64%
Revenue from Operations
42.64%
Total Assets
40.49%
Profit or Loss
-6.78%
Net Worth
142.61%
EBITDA
27.90%

What is the Ownership and Shareholding Structure of Okinawa Pharmaceuticals?

In 2020, Okinawa Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹3.40 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 0.34 Cr

Latest Charge Details

DateLenderAmountStatus
24 Apr 2021Hdfc Bank Limited₹3.40 MOpen

How Many Employees Work at Okinawa Pharmaceuticals?

Okinawa Pharmaceuticals has a workforce of 32 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Okinawa Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Okinawa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Okinawa Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Okinawa Pharmaceuticals

Recent activity within the organization

  • Director Appointment

    Srujana Bitra was appointed as a Additional Director was appointed as a Additional Director on 06 Apr 2024 & has been associated with this company since 1 year 1 month .

  • Director Appointment

    Anjaneyulu Boddapati was appointed as a Additional Director was appointed as a Additional Director on 06 Apr 2024 & has been associated with this company since 1 year 1 month .

  • Director Appointment

    Venkatrao Mandati was appointed as a Additional Director was appointed as a Additional Director on 04 Apr 2024 & has been associated with this company since 1 year 1 month .

  • Director Appointment

    Divyakolu Ramanjaneyulu was appointed as a Additional Director was appointed as a Additional Director on 04 Apr 2024 & has been associated with this company since 1 year 1 month .

  • Annual General Meeting

    Okinawa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Okinawa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

Frequently asked questions

  • What is the Incorporation or founding date of Okinawa Pharmaceuticals Private Limited?

    Okinawa Pharmaceuticals Private Limited was incorporated on 30 Dec 2015.

  • What is authorized share capital and paid-up capital of Okinawa Pharmaceuticals Private Limited?

    The authorized share capital of Okinawa Pharmaceuticals Private Limited is ₹ 5.00 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Okinawa Pharmaceuticals Private Limited?

    Currently 6 directors are associated with Okinawa Pharmaceuticals Private Limited.

    • Ramadevi Ananthu
    • Chandra Sekhara Reddy Eduru
    • Srujana Bitra
    • Venkatrao Mandati
    • Anjaneyulu Boddapati
    • Divyakolu Ramanjaneyulu

  • What is the registered address of Okinawa Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Okinawa Pharmaceuticals Private Limited is Unit No.611 6Th Floor Reliables Pride Anand Nagar, Jogeshwari W Est India, Mumbai, Maharashtra, 400102.

  • What is the corporate identification number (CIN) and company number of Okinawa Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Okinawa Pharmaceuticals Private Limited is U51101MH2015PTC306595 and the company number is 306595 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Okinawa Pharmaceuticals Private Limited?

    The Official website of Okinawa Pharmaceuticals Private Limited is https://www.okinawapharma.org

  • What has been the recent revenue trend for Okinawa Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2020, the revenue trend for Okinawa Pharmaceuticals Private Limited has risen by 42.64%.

  • How many employees does Okinawa Pharmaceuticals Private Limited currently have?

    As Per 2020 financial reports, 32 employees are currently employed by Okinawa Pharmaceuticals Private Limited.

  • What change has been observed in the net worth of Okinawa Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2020 indicates that The net worth of Okinawa Pharmaceuticals Private Limited has experienced an upsurge of 142.61%.

  • What are the total open charges for Okinawa Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2020, The total open charges for Okinawa Pharmaceuticals Private Limited amount to ₹ 3.40 M.

  • When was the last Balance Sheet of Okinawa Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Okinawa Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors